Emily Arnold
Private Equity Analyst at Cambridge Enterprise Ltd.
Network origin in Emily Arnold first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Cambridge Enterprise Ltd.
 Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge.
41
| Subsidiary | Investment Managers | 41 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Emily Arnold via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SCOTTISH MORTGAGE INVESTMENT TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member | |
| Brunel University | College/University | Undergraduate Degree | |
| BEKAERT NV | Metal Fabrication | Chief Tech/Sci/R&D Officer | |
| University of Oxford | College/University | Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Praxis
 Praxis Specialty StoresRetail Trade Part of Maxeda DIY Group BV, Praxis is a Dutch company that specializes in Miscellaneous Home Furnishings Stores. The company is based in Maastricht, Netherlands. The company was founded by Anne Dobree. The CEO is Michiel de Haan. | Specialty Stores | Founder | |
Wellcome Plc
 Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Cambridge | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
ReOx Ltd.
 ReOx Ltd. Pharmaceuticals: MajorHealth Technology ReOx Ltd. discovers and develops drugs. It provides novel treatments for disease by controlling the actvity of hypoxia inducible factor. The company was founded by Christopher W. Pugh, Patrick Maxwell, Peter J. Ratcliffe, and Christopher J. Schofield in June 2003 and is headquartered in Thame, the United Kingdom. | Pharmaceuticals: Major | Founder | |
| Cranfield University | College/University | Graduate Degree | |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Chief Executive Officer Director/Board Member | |
IP2IPO Innovations Ltd.
 IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer President Corporate Officer/Principal | |
| The University of York | College/University | Undergraduate Degree | |
| University of Porto | College/University | Undergraduate Degree | |
The Cambridge Angels
 The Cambridge Angels Investment ManagersFinance The Cambridge Angels (Cambridge Angels) is a venture capital firm founded in 1999 by Robert Sansom, David Cleevely and Doug Richard. The firm is headquartered in London, United Kingdom. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Bayes Business School | College/University | Masters Business Admin | |
| FRONTIER IP GROUP PLC | Miscellaneous Commercial Services | Director/Board Member | |
| EVANS MEDICAL PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sphere Fluidics Ltd.
 Sphere Fluidics Ltd. BiotechnologyHealth Technology Sphere Fluidics Ltd. develops technology platform for single cell analysis and characterization. Its products include Picodroplet single cell assay and isolation system, Cyto-Mine, ESI-Mine, Pico-Break, Pico-Glide, Pico-Surf, and Pico-Gen Picodroplet formation chips. It provides technology and expertise for research projects, technology development collaborations, and discovery partnerships. The company was founded by Christopher Abell and Wilhelmus Theodorus Stefanus Huck in 2010 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
ams Sensors UK Ltd.
 ams Sensors UK Ltd. Industrial MachineryProducer Manufacturing AMS Sensors UK Ltd. provides gas sensor solutions for consumer applications. The company was founded on June 20, 2007 and is headquartered in Cambridge, the United Kingdom. | Industrial Machinery | Founder Director/Board Member | |
The Acteon Consultancy LLP
 The Acteon Consultancy LLP Commercial Printing/FormsCommercial Services The Acteon Consultancy LLP designs and develops communication and learning solutions to empower growth, change and development. It services include digital & blended learning, strategy and design, communication, mobile, video, animations, workbooks, gamification, coaching tools and learning management. The company is headquartered in Cambridge, the United Kingdom. | Commercial Printing/Forms | Corporate Officer/Principal | |
| OXFORD BIODYNAMICS PLC | Biotechnology | Director/Board Member | |
Autifony Therapeutics Ltd.
 Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin | |
Aqdot Ltd.
 Aqdot Ltd. Chemicals: Major DiversifiedProcess Industries Aqdot Ltd. develops novel fabrication technology for smart capsules. Its technology simplifies the encapsulation process by utilizing the novel one-step, "shrink-wrap" approach based on a combination of emulsion technology and supramolecular chemistry. The company was founded by Jing Zhang, Chris Abell, Oren Scherman, and Roger Coulston in 2012 and is headquartered in Cambridge, the United Kingdom. | Chemicals: Major Diversified | Director/Board Member | |
DefiniGEN Ltd.
 DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Fluidic Analytics Ltd.
 Fluidic Analytics Ltd. BiotechnologyHealth Technology Fluidic Analytics Ltd. develops proprietary technology to characterize proteins. The company was founded by Tuomas Knowles in 2013 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Morphogen-IX Ltd.
 Morphogen-IX Ltd. Miscellaneous Commercial ServicesCommercial Services Morphogen-IX Ltd. operates as a biotechnology company. It develops bone morphogenetic proteins as a novel therapy for the treatment of Pulmonary Arterial Hypertension. The company was founded in 2015 and is headquartered in Babraham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| Global Medical Excellence Cluster | Director/Board Member | ||
| Cambridge University Health Partners | Director/Board Member | ||
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Executive Officer Director/Board Member | |
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Biotechnology | Director/Board Member | |
Liver Group Charity
 Liver Group Charity Miscellaneous Commercial ServicesCommercial Services Liver Group Charity operates as a charity. The private company is based in London, UK. | Miscellaneous Commercial Services | Chairman | |
Qkine Ltd.
 Qkine Ltd. Pharmaceuticals: OtherHealth Technology Qkine Ltd. provides growth factors and bioactive proteins for use in stem cell science and regenerative medicine applications. Its products include Activin A and FGF2. The firm specializes in protein purification, organoids, cytokines, and protein-engineering. The company was founded by Marko Hyvonen and Catherine Elton in 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
Polyprox Therapeutics Ltd.
 Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Pharmenable Ltd.
 Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Spirea Ltd.
 Spirea Ltd. BiotechnologyHealth Technology Spirea Ltd. operates as a healthcare technology company. It develops smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines. The company was founded by Myriam Ouberai and is headquartered in arrogate, the United Kingdom. | Biotechnology | Director/Board Member | |
Ryse Asset Management LLP
 Ryse Asset Management LLP Investment ManagersFinance RYSE Asset Management LLP (RYSE) is a venture capital firm founded in 2010 by Atique Mirza. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor | |
HexagonFab Ltd.
 HexagonFab Ltd. Medical SpecialtiesHealth Technology HexagonFab Ltd. develops biological sensors that enable rapid and cost-effective detection of biological substances such as proteins, DNA, or small molecules. The company is based in Cambridge, UK. The British company's award-winning technology eliminates the need for lengthy and expensive lab processes. The sensors can measure Antibody Antigen kinetics with the HexagonFab Bolt. The company was founded by Ruizhi Wang, Christoph von Bieberstein, Stephan Hofmann. | Medical Specialties | Director/Board Member | |
SDS Therapeutics Ltd.
 SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Sheffield Amrc | College/University | Doctorate Degree | |
| Anglia Ruskin University | College/University | Masters Business Admin | |
Acacia Capital Partners Ltd.
 Acacia Capital Partners Ltd. Investment ManagersFinance Acacia Capital Partners Ltd. is an Independent Venture Capital firm founded in 2000 by Ajay Chowdhury. The firm is headquartered in Cambridge. | Investment Managers | Founder | |
| Cambridge University Hospitals NHS Foundation Trust | Hospital/Nursing Management | Director/Board Member |
Statistics
International
| United Kingdom | 46 |
| Belgium | 2 |
| Netherlands | 2 |
| Portugal | 2 |
| Nigeria | 2 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 11 |
| Commercial Services | 10 |
| Finance | 4 |
| Producer Manufacturing | 3 |
Operational
| Director/Board Member | 89 |
| Corporate Officer/Principal | 44 |
| Private Equity Investor | 20 |
| Founder | 11 |
| Chief Executive Officer | 11 |
Most connected contacts
| Insiders | |
|---|---|
| David Holbrook | 23 |
| Ajay Chowdhury | 21 |
| Anthony Charles Hickson | 18 |
| Pamela Garside | 12 |
| John Halfpenny | 11 |
| Keith Blundy | 11 |
| Christine Martin | 11 |
| Patrick Maxwell | 9 |
| Anne Dobree | 8 |
| Bradley Hardiman | 7 |
| Florin Udrea | 7 |
| Amanda Wooding | 6 |
| Adam Martin Glinsman | 5 |
| Nigel Slater | 5 |
| Mike Arnott | 4 |
- Stock Market
- Insiders
- Emily Arnold
- Company connections
